-
公开(公告)号:US20070037791A1
公开(公告)日:2007-02-15
申请号:US11503405
申请日:2006-08-14
申请人: Thomas Rawson , Brian Safina , Jennafer Dotson , Aihe Zhou , Ignacio Aliagas-Martin , Jason Halladay , Jun Liang , Matthias Rueth , Bing-Yan Zhu
发明人: Thomas Rawson , Brian Safina , Jennafer Dotson , Aihe Zhou , Ignacio Aliagas-Martin , Jason Halladay , Jun Liang , Matthias Rueth , Bing-Yan Zhu
IPC分类号: A61K31/55 , A61K31/538 , A61K31/498 , A61K31/43 , A61K31/424 , A61K31/4188 , C07D498/22
CPC分类号: C07D487/04 , C07D491/04
摘要: The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment malignancies where the compounds have the general formula I wherein A, X, Y, Z, Ra, Rb, Rc, R1, R2, R3 and m are defined herein.
摘要翻译: 本发明提供了新的激酶抑制剂,其可用作例如治疗恶性肿瘤的治疗剂,其中化合物具有通式I,其中A,X,Y,Z,R a,R b,R c,R 1, R 2,R 3和m如本文所定义。
-
公开(公告)号:US08377937B2
公开(公告)日:2013-02-19
申请号:US12667850
申请日:2008-07-03
申请人: Josef R. Bencsik , James F. Blake , Nicholas C. Kallan , Ian S. Mitchell , Keith L. Spencer , Dengming Xiao , Rui Xu , Christine Chabot , Jun Liang , Brian S. Safina
发明人: Josef R. Bencsik , James F. Blake , Nicholas C. Kallan , Ian S. Mitchell , Keith L. Spencer , Dengming Xiao , Rui Xu , Christine Chabot , Jun Liang , Brian S. Safina
IPC分类号: C07D239/70 , A61K31/517
CPC分类号: C07D239/70 , C07D401/12 , C07D403/12 , C07D409/12
摘要: The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
摘要翻译: 本发明提供了式I化合物,包括互变异构体,拆分的对映异构体,非对映异构体,溶剂合物,代谢物,盐和药学上可接受的前药。 还提供了使用本发明化合物作为AKT蛋白激酶抑制剂和治疗过度增殖性疾病如癌症的方法。
-
公开(公告)号:US20110245230A1
公开(公告)日:2011-10-06
申请号:US13160351
申请日:2011-06-14
申请人: Ian S. Mitchell , James F. Blake , Rui Xu , Nicholas C. Kallan , Dengming Xiao , Keith Lee Spencer , Josef R. Bencsik , Eli M. Wallace , Stephen T. Schlachter , Anna L. Banka , Jun Liang , Brian Safina , Jun Li , Christine Chabot
发明人: Ian S. Mitchell , James F. Blake , Rui Xu , Nicholas C. Kallan , Dengming Xiao , Keith Lee Spencer , Josef R. Bencsik , Eli M. Wallace , Stephen T. Schlachter , Anna L. Banka , Jun Liang , Brian Safina , Jun Li , Christine Chabot
IPC分类号: A61K31/397 , A61K31/497 , A61K31/5377 , A61P29/00 , A61P35/00 , A61P19/02 , A61P25/00 , A61P1/00 , A61P3/04 , A61P25/28 , A61P11/00 , A61P31/00 , A61P25/16 , A61P37/06
CPC分类号: C07D409/14 , A61K31/517 , A61K31/5377 , A61K45/06 , C07D239/70 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12
摘要: The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
-
公开(公告)号:US08003651B2
公开(公告)日:2011-08-23
申请号:US11773946
申请日:2007-07-05
申请人: Ian S. Mitchell , James F. Blake , Rui Xu , Nicholas C. Kallan , Dengming Xiao , Keith Lee Spencer , Josef R. Bencsik , Eli M. Wallace , Stephen T. Schlachter , Anna L. Banka , Jun Liang , Brian Safina , Jun Li , Christine Chabot
发明人: Ian S. Mitchell , James F. Blake , Rui Xu , Nicholas C. Kallan , Dengming Xiao , Keith Lee Spencer , Josef R. Bencsik , Eli M. Wallace , Stephen T. Schlachter , Anna L. Banka , Jun Liang , Brian Safina , Jun Li , Christine Chabot
IPC分类号: C07D239/70 , A61K31/497 , A61P35/00 , A61P29/00 , A61P25/28 , A61P9/00
CPC分类号: C07D409/14 , A61K31/517 , A61K31/5377 , A61K45/06 , C07D239/70 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12
摘要: The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
摘要翻译: 本发明提供了式I化合物,包括互变异构体,拆分的对映异构体,非对映异构体,溶剂合物,代谢物,盐和药学上可接受的前药。 还提供了使用本发明化合物作为AKT蛋白激酶抑制剂和治疗过度增殖性疾病如癌症的方法。
-
公开(公告)号:US20110166061A1
公开(公告)日:2011-07-07
申请号:US12767646
申请日:2010-04-26
申请人: John W. Erickson , Dominique P. Bridon , Martin Robitaille , Grant A. Krafft , Dong Xie , Elena Afonina , Jun Liang , Sandra De Meyer
发明人: John W. Erickson , Dominique P. Bridon , Martin Robitaille , Grant A. Krafft , Dong Xie , Elena Afonina , Jun Liang , Sandra De Meyer
CPC分类号: C07K14/005 , A61K38/00 , C07K2319/00 , C12N2740/16122
摘要: The present invention is concerned with This invention relates to C34 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to C34 derivatives having inhibiting activity against human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), human parainfluenza virus (HPV), measles virus (MeV), and simian immunodeficiency virus (SIV) with long duration of action for the treatment of the respective viral infections.
摘要翻译: 本发明涉及作为病毒感染抑制剂和/或表现出抗融合性质的C34肽衍生物。 特别地,本发明涉及具有长期持续时间的针对人免疫缺陷病毒(HIV),呼吸道合胞病毒(RSV),人副流感病毒(HPV),麻疹病毒(MeV)和猿猴免疫缺陷病毒(SIV))具有抑制活性的C34衍生物 的治疗各自病毒感染的作用。
-
公开(公告)号:US07749994B2
公开(公告)日:2010-07-06
申请号:US11503405
申请日:2006-08-14
申请人: Thomas E. Rawson , Brian Safina , Jennafer Dotson , Aihe Zhou , Ignacio Aliagas-Martin , Jason Halladay , Jun Liang , Matthias Rueth , Bing-Yan Zhu , Frederick Brookfield , Michael Prime , Birong Zhang , Jun M. Li
发明人: Thomas E. Rawson , Brian Safina , Jennafer Dotson , Aihe Zhou , Ignacio Aliagas-Martin , Jason Halladay , Jun Liang , Matthias Rueth , Bing-Yan Zhu , Frederick Brookfield , Michael Prime , Birong Zhang , Jun M. Li
IPC分类号: A61K31/55 , A61K31/538 , A61K31/424 , A61K31/4188 , C07D498/22
CPC分类号: C07D487/04 , C07D491/04
摘要: The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment malignancies where the compounds have the general formula I wherein A, X, Y, Z, Ra, Rb, Rc, R1, R2, R3 and m are defined herein.
摘要翻译: 本发明提供新的激酶抑制剂,其可用作例如治疗恶性肿瘤的治疗剂,其中化合物具有通式I,其中A,X,Y,Z,R a,R b,R c,R 1,R 2,R 3和m定义 这里。
-
公开(公告)号:US20100144732A1
公开(公告)日:2010-06-10
申请号:US12520194
申请日:2007-12-13
IPC分类号: A61K31/5377 , A61K31/505 , C07D413/02 , C07D239/02 , A61P35/04
CPC分类号: C07D239/48
摘要: The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment malignancies where the compounds have the general formula I wherein Q, X, Y, Z, R1, R2, R4, m and n are as defined herein.
摘要翻译: 本发明提供新的激酶抑制剂,其可用作例如治疗恶性肿瘤的治疗剂,其中化合物具有通式I,其中Q,X,Y,Z,R 1,R 2,R 4,m和n如本文所定义。
-
公开(公告)号:US20080318989A1
公开(公告)日:2008-12-25
申请号:US12097030
申请日:2006-12-15
申请人: Daniel J. Burdick , Jun Liang
发明人: Daniel J. Burdick , Jun Liang
IPC分类号: A61K31/506 , C07D239/24 , C12N5/00 , A61P35/00
CPC分类号: C07D403/12 , C07D409/12 , C07D413/12
摘要: The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment malignancies where the compounds have the general formula (I) wherein ring A, X, Y, Z, R1, R2, R3, R4, m and n are as defined herein.
摘要翻译: 本发明提供新的激酶抑制剂,其可用作例如治疗恶性肿瘤的治疗剂,其中化合物具有通式(I),其中环A,X,Y,Z,R 1,R 2,R 3,R 4,m和n为 如本文所定义。
-
19.
公开(公告)号:US08853216B2
公开(公告)日:2014-10-07
申请号:US12811983
申请日:2009-01-09
申请人: Josef Bencsik , James F. Blake , Nicholas C. Kallan , Ian S. Mitchell , Keith L. Spencer , Dengming Xiao , Rui Xu , Christine Chabot , Steven Do , Jun Liang , Brian Safina , Birong Zhang , James Graham
发明人: Josef Bencsik , James F. Blake , Nicholas C. Kallan , Ian S. Mitchell , Keith L. Spencer , Dengming Xiao , Rui Xu , Christine Chabot , Steven Do , Jun Liang , Brian Safina , Birong Zhang , James Graham
IPC分类号: C07D239/70 , A61K31/517 , A61P35/00 , A61P29/00 , A61P25/00 , A61P9/00 , A61P15/02 , A61P17/00
CPC分类号: C07D239/70
摘要: The present invention provides a compound and pharmaceutically acceptable salts thereof, comprising the Formula I. Also provided are methods of using the compound of this invention as an AKT protein kinase inhibitor and for the treatment of hyperproliferative diseases such as cancer.
摘要翻译: 本发明提供了包含式I的化合物及其药学上可接受的盐。还提供了使用本发明化合物作为AKT蛋白激酶抑制剂和治疗过度增殖性疾病如癌症的方法。
-
公开(公告)号:US20130265765A1
公开(公告)日:2013-10-10
申请号:US13814937
申请日:2012-06-01
申请人: Jun Liang , Wenying Yong , Zhan Liang
发明人: Jun Liang , Wenying Yong , Zhan Liang
IPC分类号: H05K5/02
CPC分类号: H05K5/0208 , G09F9/3026
摘要: The invention relates to a quick installation multifunctional display comprising at least two display units, connecting pieces for connecting the display units together; said display unit comprises a frame formed by four side walls, and through-holes are formed in the side walls of the frame, said connecting pieces connect the display units together by the through-holes in the side walls of the frame. The quick installation multifunctional display of the present invention could be formed by connecting the display units together through the connecting pieces, which makes the installation very convenient; furthermore, the workload and time for installation of the quick installation multifunctional display could be decreased, which lowers the installation costs.
摘要翻译: 本发明涉及一种快速安装多功能显示器,其包括至少两个显示单元,用于将显示单元连接在一起的连接件; 所述显示单元包括由四个侧壁形成的框架,并且在框架的侧壁中形成通孔,所述连接件通过框架的侧壁中的通孔将显示单元连接在一起。 本发明的快速安装多功能显示器可以通过连接件将显示单元连接在一起形成,这使得安装非常方便; 此外,可以减少安装快速安装多功能显示器的工作量和时间,这降低了安装成本。
-
-
-
-
-
-
-
-
-